Open main menu
Home
Random
Donate
Recent changes
Special pages
Community portal
Preferences
About Stockhub
Disclaimers
Search
User menu
Talk
Contributions
Create account
Log in
Editing
Gendius
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Team== Gendius is headed up by Rory Cameron (CEO) an experienced pharmaceutical and mHealth leader who has built and exited successful companies. Rory is passionate to ensure that Gendius operates at the highest ethical standards. Co-founder Chris Genders is also a seasoned pharmaceutical industry professional, operating to director level. The original idea for intellin came from Chris's diagnosis of diabetes 15 years ago, and his passion is use mHealth and technology to help those with diabetes live better and understand their condition. Chair Albert Nicholl has many years of experience in med tech industry and now spends his time as a coach and mentor for entrepreneurs. Further Board advisors include Charles Toomey, James Crossland and Dr Natasha Patel. The motivation comes from a personal experience of just how hard diabetes can be. Many apps exist that tell you how you've been doing (the rear-view mirror) while intellin helps you understand the road ahead (sat-nav). intellin has been proven as a capable remote monitoring platform and has been rated on the NHS backed Orcha platform which has driven greater engagement during the Covid crisis. Post COVID, we aim to develop the concept even further working alongside not only the NHS but private providers too. We believe the current pandemic has identified the need for remote management of people with diabetes. Intellin is that solution. [[Category:Thesis]] [[Category:Equities]] __INDEX__
Summary:
Please note that all contributions to Stockhub may be edited, altered, or removed by other contributors. If you do not want your writing to be edited mercilessly, then do not submit it here.
You are also promising us that you wrote this yourself, or copied it from a public domain or similar free resource (see
Stockhub:Copyrights
for details).
Do not submit copyrighted work without permission!
Cancel
Editing help
(opens in new window)